Extracorporeal magnetotransduction therapy

from Wikipedia, the free encyclopedia

The Extracorporeal Magnetotransduktionstherapie (EMTT) is a form of therapy for the treatment of (chronic) musculoskeletal diseases.

The areas of application include degenerative joint diseases, pain therapy and sports injuries. The effectiveness of EMTT has already been proven in several clinical studies for individual indications.

The therapy is a non-invasive , outpatient treatment solution in which painful areas of the body are treated with high-energy magnetic pulses. With EMTT, the magnetic field is typically generated by a weakly damped resonant circuit . This consists of a coil and a capacitor , which is charged by a high voltage source with a very high voltage. After the capacitor has discharged, several kiloamps of electrical current flow through the coil, creating a magnetic field. The amplitude and spatial distribution can be calculated using the Biot-Savart law . Due to the high frequency and the strong magnetic field, EMTT devices typically have magnetic field gradients of 60,000 T / s up to 150,000 T / s. Pulse repetition rates of several Hz are possible. Due to the very high oscillation frequency (100 - 300 kHz), EMTT differs from other general forms of magnetic field therapy or PEMF (pulsating magnetic field therapy).

Web links

Individual evidence

  1. André Krath et al., J. Orthop. 2017; 14 (3): 410-415. doi: 10.1016 / j.jor.2017.06.016.
  2. Tim Klüter et al., Electromagn Biol Med. 2018; 37 (4): 175-183. doi: 10.1080 / 15368378.2018.1499030.
  3. Tim Klueter et al., J Orthop Ther. 2018: JORT-1113. doi: 10.29011 / 2575-8241.001113
  4. Ludger Gerdesmeyer et al., J Foot Ankle Surg. 2017; 56 (5): 964-967. doi: 10.1053 / j.jfas.2017.06.014.